Canadian-made COVID-19 antibody treatment sitting on shelves due to lack of administration plan kake.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kake.com Daily Mail and Mail on Sunday newspapers.
TORONTO A Canadian-made COVID-19 antibody treatment is sitting on hospital and pharmacy shelves amid the countryâs third wave of the pandemic because doctors say a plan on how to administer the drug was never made. âIt s actually very frustrating that we have a therapy available to us that we re not actually able to use,â said infectious disease expert Dr. Deepali Kuma. Bamlanivimab is a monoclonal antibody directed against the spike protein of SARS-CoV-2, the virus that causes COVID-19. The drug mimics the immune system s ability to fight off the virus and was developed by AbCellera Biologics Inc. in Vancouver with the support of the federal government, which had committed up to $175.6 million to the company in May 2020 to develop antibody therapies.